06-09-2026 16:08 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  About Us   Services             Trading   Depository    
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Quarterly Results
Aurobindo Pharma Ltd.
 
BSE Code 524804
ISIN Demat INE406A01037
Book Value 407.63
NSE Code AUROPHARMA
Dividend Yield % 0.24
Market Cap 951272.27
P/E 36.69
EPS 45.06
Face Value 1  
Quarters :
(Rs. in Million)
Particulars (Rs in Million) Jun 2026Mar 2026Dec 2025Sep 2025
 Audited / UnAudited UnAudited UnAudited UnAudited UnAudited
Net Sales 27995.10 27865.50 27472.80 27897.20
Total Expenditure 19172.60 20051.30 19578.00 20650.20
PBIDT (Excl OI) 8822.50 7814.20 7894.80 7247.00
Other Income 2418.90 2140.90 1301.50 1595.20
Operating Profit 11241.40 9955.10 9196.30 8842.20
Interest 470.70 472.70 484.30 574.50
Exceptional Items 0 0 -173.80 0
PBDT 10770.70 9482.40 8538.20 8267.70
Depreciation 689.90 719.30 719.20 714.90
Profit Before Tax 10080.80 8763.10 7819.00 7552.80
Tax 2708.60 1840.80 1998.30 1739.10
Provisions and contingencies 0 0 0 0
Profit After Tax 7372.20 6922.30 5820.70 5813.70
Extraordinary Items 0 0 0 0
Prior Period Expenses 0 0 0 0
Other Adjustments 0.00 0.00 0.00 0.00
Net Profit 7372.20 6922.30 5820.70 5813.70
Equity Capital 575.40 580.80 580.80 580.80
Face Value (IN RS) 1 1 1 1
Reserves    
Calculated EPS 12.81 11.92 10.02 10.01
Calculated EPS (Annualised) 51.25 47.67 40.09 40.04
No of Public Share Holdings 276855169.00 279852902.00 279852902.00 279852902.00
% of Public Share Holdings 48.12 48.18 48.18 48.18
     
PBIDTM% (Excl OI) 31.51 28.04 28.74 25.98
PBIDTM% 40.15 35.73 33.47 31.70
PBDTM% 38.47 34.03 31.08 29.64
PBTM% 36.01 31.45 28.46 27.07
PATM% 26.33 24.84 21.19 20.84
 Notes Notes Notes Notes
 
Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Few Important Links: NSE | BSE | NSDL | CDSL | SEBI | MCX | NCDEX | FMC | RBI | AMFI | My Company GST Number | SCORES | DP 15 | BSE PLUS
Contact Us | Careers | Downloads | Notice |Margin Obligation Circular |Creating Investor | Policies| Details of KMPS | Public information for Investors
Circular | BOI UPI ID & QR Code | Reasearch Analyst Certificate
SEBI Reg. No INZ000209538 Depository CDSL: IN-DP-15-2015 Research Reg. No.: INH000011219
© 2006 J G Shah Financial Consultants Pvt.Ltd. All rights reserved.
Designed || Developed & Content Powerd By Accord Fintech Pvt. Ltd.